Skip to content

Radiostereometric Analysis of Acetabular Wear and Periprosthetic Bone Mineral Density Changes in Hemiarthroplasties

Radiostereometric Analysis of Acetabular Wear and Periprosthetic Bone Mineral Density Changes in Cemented and Uncemented Hemiarthroplasties for Femoral Neck Fractures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00607516
Acronym
HEMI-RSADEXA
Enrollment
22
Registered
2008-02-05
Start date
2006-03-31
Completion date
2009-01-31
Last updated
2009-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acetabular Wear, Bone Density, Femoral Neck Fractures, Hemiarthroplasty

Keywords

fracture, arthroplasty, wear, osteoporosis, bone

Brief summary

Substudy and continuation of HEMI-SAB-UUS (NCT00491673) Study on radiostereometric measurements of acetabular wear in bipolar hemiarthroplasties and measurements of periprosthetic bone mineral density in cemented and uncemented hemiarthroplasties in patients with femoral neck fractures. Null hypothesis: No difference in acetabular wear or in bone mineral density changes between cemented and uncemented hemiarthroplasties

Detailed description

Patients are randomised to treatment with cemented or uncemented bipolar hemiarthroplasty. 1mm tantalum markers are inserted in the pelvis during surgery. RSA X-rays and DEXA measurements conducted postoperatively, after 3 and 12 months. Follow-up visits and clinical examination at 3 and 12 months.

Interventions

Cemented primary bipolar hemiarthroplasty of the hip

Uncemented primary bipolar hemiarthroplasty of the hip

Sponsors

Ullevaal University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Femoral neck fracture * 65 years or older * Able to walk independently

Exclusion criteria

* Cognitive dysfunction * Infection * Fracture caused by malignant disease

Design outcomes

Primary

MeasureTime frame
Acetabular wear in mm1 year
Loss of bone mineral density (BMD)1 year

Secondary

MeasureTime frame
Functional outcome including pain (Harris Hip Score)1 year
Activities Of Daily Living (Barthels ADL-Index)1 year
Quality Of Life (EQ-5D)1 year

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026